---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-25-000108"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T17:40:50.449717+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst Q2 revenue $80.7M (+6% YoY), EBITDA $9.3M beat; CEO to retire June 2026

## Summary
- Total revenue $80.7M (+6% YoY); Adjusted EBITDA $9.3M; both beat Q2 guidance.
- Net loss widened 203% to $41.0M from $13.5M in prior year.
- CEO Dan Burton to retire effective June 30, 2026; will remain on Board; CEO search initiated.
- Board expanded to 8 directors; Justin Spencer (CFO Eko Health) appointed effective Sep 1, 2025.

## SEC filing metadata
- accession: 0001636422-25-000108
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642225000108/0001636422-25-000108-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642225000108/hcat-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-25-000108
- JSON: https://secwatch.observer/filing/0001636422-25-000108.json
- Plain text: https://secwatch.observer/filing/0001636422-25-000108.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.